Welcome to Critical Mass, Law.com’s weekly briefing on class actions and mass torts. I’m Amanda Bronstad in Los Angeles. U.S. Supreme Court nominee Brett Kavanaugh has a thin record on class actions and mass torts — but there are some clues about how he’d rule. What could Johnson & Johnson argue in appealing last week’s $4.7 billion talcum powder verdict? And I asked a lead plaintiffs’ attorney in this month’s record $1.5 billion shareholder settlement in the Netherlands how his firm brings class actions in Europe.
Send your feedback to [email protected], or find me on Twitter: @abronstadlaw.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]